Wednesday 18 December 2024

Pharma & Biotech Start-up & Scale-up News

Featured

Viridian Therapeutics
A biotechnology company advancing new treatments for patients suffering from serious diseases underserved by current therapies.
Pharmaceutical
Lexicon pivots back to pipeline after FDA rejection
25 November 2024
Pharmaceutical
The week in pharma: action, reaction and insight – week to November 1
3 November 2024

Latest Ones To Watch News

Biotechnology
Theranexus leaps on deal with Exeltis to commercialize TX01
18 December 2024
Biotechnology
Viridian veers upwards on Phase III success
17 December 2024
Biotechnology
Gilead inks multi-target deal with Terray Therapeutics
17 December 2024
More ones to watch news >
Reset all filters
Refine Search
Enanta Pharmaceuticals
Basilea
Basilea
Exsilio Therapeutics
Aphaia Pharma
Avextra
Aurion Biotech
āshibio
UTILITY Therapeutics
Enlaza Therapeutics
Jacobio Pharma
SFA Therapeutics
Reunion Neuroscience
Atopia Therapeutics
Prologue Medicines
Lykos Therapeutics
Attovia Therapeutics
Ajax Therapeutics
Cartesian Therapeutics
AltruBio
Progentos Therapeutics


Today's issue

Egypt approves EVA and Lilly’s insulin glargine
Biotechnology
Egypt approves EVA and Lilly’s insulin glargine
18 December 2024
Biotechnology
Merck & Co cuts TIGIT and LAG-3 programs
18 December 2024
Biotechnology
Broader Eylea HD label on the cards after Phase III win
18 December 2024
Biotechnology
Theranexus leaps on deal with Exeltis to commercialize TX01
18 December 2024
Pharmaceutical
Airing in journal a further step forward for ENA Respiratory
18 December 2024
Pharmaceutical
$45 million investment to boost African vaccine production
18 December 2024
Pharmaceutical
Pfizer provides full-year 2025 guidance
18 December 2024

Company Spotlight

A biotechnology company advancing new treatments for patients suffering from serious diseases underserved by current therapies.




Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze